Boehler Adam's Form 4 filing
Privia Health Group, Inc. (PRVA) · filed May 23, 2024
- Accession no.
- 0001759655-24-000091
- Filed
- May 23, 2024
- Trade date
- May 21-23, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $8.98M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boehler AdamCIK 0001982325 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2024 | Common Stock, $0.01 par value per share | PPurchaseAcquired | +277,565 | $16.17 | +$4,488,226.05 | 5,488,701 | Indirect | |
| May 22, 2024 | Common Stock, $0.01 par value per share | PPurchaseAcquired | +102,229 | $16.43 | +$1,679,622.47 | 5,590,930 | Indirect | |
| May 23, 2024 | Common Stock, $0.01 par value per share | PPurchaseAcquired | +172,642 | $16.28 | +$2,810,611.76 | 5,763,572 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.